Rating History for Actuate Therapeutics (ACTU) by B.Riley

More Stocks Rated by B.Riley | Latest Ratings for ACTU
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
8/26/2025 Mayank Mamtani New Coverage Buy
(N/A)		 20.00
(N/A)		 8.36
(2.86)		 -65.79% Details